Press "esc" to clear
Go to Advanced Search
Showing results 3140 of 1504
  • Embargo expired:
    6-Aug-2018 11:00 AM EDT

Article ID: 698480

Enzyme Helps Build Motor That Drives Neuron Death

Vanderbilt University

The process, discovered in the axons of neurons, is implicated in Alzheimer’s, amyotrophic lateral sclerosis, traumatic brain injury and other diseases or injuries to the nervous system.

2-Aug-2018 12:00 PM EDT

Article ID: 698454

pH Imbalance in Brain Cells May Contribute to Alzheimer’s Disease

Johns Hopkins Medicine

Johns Hopkins Medicine scientists say they have found new evidence in lab-grown mouse brain cells, called astrocytes, that one root of Alzheimer’s disease may be a simple imbalance in acid-alkaline—or pH—chemistry inside endosomes, the nutrient and chemical cargo shuttles in cells.

2-Aug-2018 12:00 PM EDT

Article ID: 698390

Study: Nine Out of 10 People Caring for a Family Member with Dementia Don’t Get Enough Sleep

University at Buffalo

More than 90 percent of people caring for a family member with dementia experience poor sleep, according to new research by the University at Buffalo School of Nursing.

1-Aug-2018 12:05 PM EDT

Article ID: 698342

$250K Grant Awarded to Rutgers Cancer Institute of New Jersey Researchers

Rutgers Cancer Institute of New Jersey

Rutgers researchers will benefit from a $250,000 grant from the Gillson Longenbaugh Foundation to help expand the team’s work on neural stem cell interactions and developing antibody therapeutics for cancer treatment.

31-Jul-2018 2:05 PM EDT

Article ID: 698299

Glaucoma Research Foundation Grant Leads to Major Breakthrough in Neuron Regeneration

Glaucoma Research Foundation

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma. The research, which was made possible by a Glaucoma Research Foundation Shaffer Grant, could also be applicable to other neurodegenerative diseases, including Alzheimer's disease.

31-Jul-2018 7:00 AM EDT

Article ID: 698240

Fujirebio Enters into Agreement With Janssen Pharmaceuticals to Develop and Commercialize Amyloid β 42/40 ratio Assay

70th AACC Annual Scientific Meeting Press Program

Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced today that it has entered into an agreement with US-based Janssen Pharmaceuticals, Inc. (hereinafter “Janssen”) to develop and commercialize an AMYLOID β 42/40 RATIO assay.

30-Jul-2018 12:05 PM EDT
  • Embargo expired:
    26-Jul-2018 11:00 AM EDT

Article ID: 697867

Can Scientists Leverage Mysterious Mossy Cells for Brain Disease Treatments?

University of North Carolina Health Care System

A small population of brain cells called "mossy cells" deep in a memory-making region of the brain controls the production of new neurons and may have a role in common brain disorders, according to a study from scientists at the University of North Carolina School of Medicine.

24-Jul-2018 4:05 PM EDT
  • Embargo expired:
    25-Jul-2018 4:00 PM EDT

Article ID: 697685

Feel Lightheaded When Standing Up? You May Have a Greater Risk of Dementia

American Academy of Neurology (AAN)

People who feel faint, dizzy or lightheaded when standing up may be experiencing a sudden drop in blood pressure called orthostatic hypotension. Now a new study says middle-aged people who experience such a drop may have a greater risk of developing dementia or stroke decades later. The study is published in the July 25, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19-Jul-2018 4:35 PM EDT

Article ID: 698007

Landmark Trial Using Focused Ultrasound in Alzheimer’s Patients Presented at AAIC Meeting, Published in Nature Communications

Focused Ultrasound Foundation

The results of the first ever clinical trial of focused ultrasound to open the blood-brain barrier (BBB) in patients with Alzheimer’s disease were published today in Nature Communications and also presented at the Alzheimer’s Association International Conference (AAIC) in Chicago, Illinois. The pilot trial demonstrated the feasibility and preliminary safety of focally, reversibly and repetitively opening the BBB.

25-Jul-2018 1:05 PM EDT

Showing results 3140 of 1504

Chat now!